These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26870350)

  • 21. ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.
    Guo C; Ma J; Deng G; Qu Y; Yin L; Li Y; Han Y; Cai C; Shen H; Zeng S
    J Cancer; 2017; 8(17):3555-3566. PubMed ID: 29151941
    [No Abstract]   [Full Text] [Related]  

  • 22. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
    Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
    World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
    Chen D; Wang J; Zhang Y; Chen J; Yang C; Cao W; Zhang H; Liu Y; Dou J
    Int J Gynecol Cancer; 2013 Oct; 23(8):1357-66. PubMed ID: 24257549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
    Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
    Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of ZEB1 and Vimentin with poor prognosis in metaplastic breast cancer.
    Zawati I; Jlassi A; Adouni O; Nouira M; Manai M; Rahal K; Driss M; Manai M
    Ann Diagn Pathol; 2022 Aug; 59():151954. PubMed ID: 35523002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
    Liu R; Zheng J; Li C; Pang Y; Zheng Q; Xu X; Liu P
    Arch Gynecol Obstet; 2015 Jun; 291(6):1361-9. PubMed ID: 25424898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZEB1 promotes epithelial-mesenchymal transition in cervical cancer metastasis.
    Ran J; Lin DL; Wu RF; Chen QH; Huang HP; Qiu NX; Quan S
    Fertil Steril; 2015 Jun; 103(6):1606-14.e1-2. PubMed ID: 25963537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger-1 (NHE1).
    Dykes SS; Gao C; Songock WK; Bigelow RL; Woude GV; Bodily JM; Cardelli JA
    Mol Carcinog; 2017 Feb; 56(2):722-734. PubMed ID: 27434882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aberrant expressions of MACC1, ZEB1, and KLF4 in hepatocellular carcinoma and their clinical significance.
    Chen J; Zhang L; Ma S; Lu G; Wang D
    Int J Clin Exp Pathol; 2019; 12(9):3653-3661. PubMed ID: 31934216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
    Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
    Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PARK2 negatively regulates the metastasis and epithelial-mesenchymal transition of glioblastoma cells via ZEB1.
    Wang H; Jiang Z; Na M; Ge H; Tang C; Shen H; Lin Z
    Oncol Lett; 2017 Sep; 14(3):2933-2939. PubMed ID: 28928831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-186-5p upregulation inhibits proliferation, metastasis and epithelial-to-mesenchymal transition of colorectal cancer cell by targeting ZEB1.
    Li J; Xia L; Zhou Z; Zuo Z; Xu C; Song H; Cai J
    Arch Biochem Biophys; 2018 Feb; 640():53-60. PubMed ID: 29325758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
    Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
    J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AKIP1 promoted epithelial-mesenchymal transition of non-small-cell lung cancer via transactivating ZEB1.
    Guo X; Zhao L; Cheng D; Mu Q; Kuang H; Feng K
    Am J Cancer Res; 2017; 7(11):2234-2244. PubMed ID: 29218247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines.
    Orellana-Serradell O; Herrera D; Castellon EA; Contreras HR
    Asian J Androl; 2018; 20(3):294-299. PubMed ID: 29271397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and clinicopathological significance of Cacna2d1 expression in epithelial ovarian cancers: a retrospective study.
    Yu D; Holm R; Goscinski MA; Trope CG; Nesland JM; Suo Z
    Am J Cancer Res; 2016; 6(9):2088-2097. PubMed ID: 27725913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.